ACCESS Newswire

Nikon Inc.

29.4.2024 23:14:54 CEST | ACCESS Newswire | Press release

Share
Nikon Becomes Official Rangefinder of the LPGA and LET

Nikon to Provide COOLSHOT Rangefinders to All Active Athletes Across Both Tours

DAYTONA BEACH, FL / ACCESSWIRE / April 24, 2024 / The Ladies Professional Golf Association (LPGA) and Ladies European Tour (LET) proudly announce a new multi-year partnership with Nikon Inc., a leader in imaging products, optics, precision equipment and instruments.

Nikon's COOLSHOT Rangefinders will become the Official Rangefinders of both Tours, offering precision optical devices designed to deliver unparalleled accuracy in distance measurement. With cutting-edge technology and sleek design, Nikon Rangefinders promise superior performance in diverse scenarios, blending precision, innovation, and durability seamlessly to empower confident decision-making during play.

"To Nikon, this is more than a partnership - it's a fantastic opportunity to support a diverse group of amazing and talented athletes, who can use our optics and rangefinders to take their already impressive game even further," said Naoki Onozato, President and CEO, Nikon Inc. "We can't wait to see how these tours grow and thrive in the future, and we are proud to be a part of it."

As part of the partnership, LPGA and LET players will receive Nikon Rangefinders for use during competition and practice, with the rangefinders featuring a special competition mode to comply with the Rules of Golf. Nikon's commitment underscores its dedication to equipping athletes with the tools necessary for success at the highest level.

"We are so thrilled to announce Nikon as our newest official partner, providing high-quality equipment that supports the success of our athletes," said LPGA Chief Sales and Partnerships Officer Nicole Metzger. "This partnership directly benefits our athletes by providing them with top-of-the-line equipment that enhances their performance and confidence on the course. We are constantly looking to work with corporations like Nikon who share our dedication to growing and elevating the sport and empowering female athletes worldwide."

Rangefinders were first allowed in LPGA Tour competition at the 2021 KPMG Women's PGA Championship, with athletes now permitted to use rangefinder technology at most LPGA Tour and LET events. The Epson Tour and LET Access Series have permitted the usage of rangefinders in competition since 2020.

"We are excited to welcome Nikon to the LET family as the Official Rangefinder to the Tour for the next two years," said Fiona Harold, Commercial Director of the LET. "It's key for us that we align with partners who support our objectives, and this is a great example of that. Nikon's investment means our players will benefit from using the best equipment to enable them to excel on the golf course. Their commitment to partnering with both the LET and the LPGA shows the value they place on supporting elite female golfers competing across the globe. We are really looking forward to working with them."

For more information and to explore the products offered by Nikon, visit NikonUSA.com.

Full PR here: https://www.nikonusa.com/press-room/lpga

Contact Information

Geoff Coalter
Communications Strategy and PR Manager
geoffrey.coalter@nikon.com
201-289-7871

J.D Sterba
Director, Public Relations & Executive Communications
jd.sterba@lpga.com

SOURCE: Nikon Inc.

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye